(Update) Acalabrutinib in CLL and MCL
Update Venetoclax in CLL
Zanubrutinib
Obinutuzumab
NCCN COVID-19 Resources Page
NCCN Guidelines for Patients for CLL
Cancer.gov
UpToDate